This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Radiation Therapy Equipment Industry

NEW YORK, Dec. 11, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

Global Radiation Therapy Equipment Industry

This report analyzes the worldwide markets for Radiation Therapy Equipment in US$ Million by the following Product Segments: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. A Six-year historic analysis is also provided for these markets. The report profiles 55 companies including many key and niche players such as Accuray Incorporated, Elekta AB, Nucletron B.V., Nordion, Inc., Philips Healthcare, Siemens Healthcare, and Varian Medical Systems, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-2Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Linear Accelerator I-3Treatment Planning System I-4Radiation Therapy Simulator I-4

II. EXECUTIVE SUMMARY1. MARKET OVERVIEW II-1Outlook II-1Current and Future Analysis II-1Replacement Sales Spur Global Radiotherapy Market II-2US Leads in Penetration of Clinical Accelerators II-2Table 1: Global Clinical Accelerators Installed Base (2011):Penetration of Clinical Accelerators for Select Countries(Installed Units per 1 Million Inhabitants) (includescorresponding Graph/Chart) II-2

2. MARKET TRENDS & ISSUES II-3Cancer's Extending Tentacles Bolsters Demand for RadiationTherapy II-3Brachytherapy Devices Market to Receive Impetus Due to GlobalSpread of Cancer II-3Table 2: Global Leading Players in Brachytherapy DevicesMarket (2011): Percentage Market Share Breakdown for Oncura,CR Bard, Ibt Bebig, Theragenics, Core Oncology, and Others(includes corresponding Graph/Chart) II-4Technology Obsolescence Drives Innovation II-4Spiraling Demand for IGRT and Motion-Detection Technology II-4Huge Finances - Imperative for Radiation Therapy EquipmentPurchases II-4Insurance Plans Determine the Feasibility of Novel Technologies II-5Developing Nations Offer Lucrative Opportunities II-5Asia Presents a Promising Market II-5Increasing Usage of Radiation Oncology Management SystemsSoftware II-6Linear Accelerators (LINACS) Increasingly Replace ConventionalEquipment II-6Cobalt-60 Units on a Decline II-6Table 3: Cobalt-60 Units Distribution Worldwide byGeographic Region (A Comparative Analysis of 1997 Vis-à-vis2007): Number of Units in Asia-Pacific, Eastern Europe,Central and South America, Western Europe, North America, Middle East & Africa, and Caribbean (includes correspondingGraph/Chart) II-7Planning Gaining its Rightful Place in Cancer Treatment II-7Aging Population Drives Radiation Therapy Equipment Market II-8Table 4: Worldwide Distribution of Population by Region/Country (2011) (includes corresponding Graph/Chart) II-8Table 5: Worldwide Distribution of 65+ Population byRegion/Country (2011) (includes corresponding Graph/Chart) II-8TomoTherapy - Future of Radiation Treatment II-8Conventional Therapy Vs. TomoTherapy II-9Current Applications II-9Proton Therapy - Revolutionizing the Industry II-10Industry Marked by Intense Competition II-10IMRT - An Insight II-11IMRT: A Breakthrough for the Treatment of Pediatric Cancer II-11Hospitals Focus on Buying IMRT-Capable LINACs II-11Adaptive Radiation Therapy (ART) Gains Significance II-11IGRT Gaining Ground II-12Technological Progress in the Treatment of Localized ProstateCancer II-12Shortage of Medical Professionals & Systems - A Major Obstacle II-12

3. CANCER - A GLOBAL CONCERN II-13Cancer Incidence - Statistics on New Cases II-13Table 6: Global Cancer Incidence by Region in Thousands(2011) (includes corresponding Graph/Chart) II-13Table 7: Global Cancer Incidence Statistics for SelectCountries: 2011 (in Thousands) (includes correspondingGraph/Chart) II-14Table 8: Global Cancer Incidence by Income Group: 2011 (inThousands) (includes corresponding Graph/Chart) II-14Table 9: Cancer Incidence in High Income Countries by Site:2011 (in Thousands) (includes corresponding Graph/Chart) II-15Table 10: Cancer Incidence in Upper Middle Income Countriesby Site: 2011 (in Thousands) (includes correspondingGraph/Chart) II-16Table 11: Cancer Incidence in Lower Middle Income Countriesby Site: 2011 (in Thousands) (includes correspondingGraph/Chart) II-17Cancer Incidence in Developing Countries II-17Cancer in Asia II-18Cancer Cases - Mortality Rates II-18Oncology - Growing at a Cancerous Rate II-18Worldwide Cancer Cases II-18Cancer Treatment Modalities II-19Radiation Therapy II-19

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs